Nicotinic acetylcholine receptors in neuropathic and inflammatory pain
- PMID: 29030971
- PMCID: PMC5899685
- DOI: 10.1002/1873-3468.12884
Nicotinic acetylcholine receptors in neuropathic and inflammatory pain
Abstract
Nicotinic acetylcholine receptors (nAChRs) are actively being investigated as therapeutic targets for the treatment of pain and inflammation, but despite more than 30 years of research, there are currently no FDA-approved analgesics that are specific for these receptors. Much of the initial research effort focused on the α4β2 nAChR subtype, but more recently, additional subtypes have been identified as promising new leads and include α6β4, α7, and α9-containing nAChRs. This Review will focus on the distribution of these nAChRs in the cell types involved in neuropathic pain and inflammation and the activity of currently available nicotinic ligands.
Keywords: cancer pain; inflammatory pain; neuropathic pain; nicotinic acetylcholine receptors; α-conotoxin RgIA.
© 2017 Federation of European Biochemical Societies.
Conflict of interest statement
References
-
- Mao D, Yasuda RP, Fan H, Wolfe BB, Kellar KJ. Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose Ganglia. Mol Pharmacol. 2006;70:1693–9. - PubMed
-
- Zhou X, Ren J, Brown E, Schneider D, Caraballo-Lopez Y, Galligan JJ. Pharmacological properties of nicotinic acetylcholine receptors expressed by guinea pig small intestinal myenteric neurons. J Pharmacol Exp Ther. 2002;302:889–97. - PubMed
-
- David R, Ciuraszkiewicz A, Simeone X, Orr-Urtreger A, Papke RL, McIntosh JM, Huck S, Scholze P. Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes. Eur J Neurosci. 2010;31:978–93. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
